Back to results
US 12,760,058 B2Granted
Prodrugs of neuroactive steroids
AssigneeBrii Biosciences, Inc.
InventorLianhong Xu
Life of this patent
Estimating the term…
Abstract
The present application relates to novel compounds that are prodrugs of brexanolone, ganaxolone and zuranolone, pharmaceutical compositions comprising one or more compounds disclosed herein and salts thereof, and a pharmaceutically acceptable excipient, and use of the compounds disclosed herein and salts thereof for treating diseases or conditions related to GABAA receptor function, such as major depression disorder (MDD) and postpartum depression (PPD), in mammals and especially in humans.
Claims3
A compound having the structure:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.